"Východoslovenský onkologický ústav Košice vznikol 1.7.2003 a dňa 20.2.2006 sa transformoval na akciovú spoločnosť s názvom Východoslovenský onkologický ústav, a.s.. Jeho poslaním je predovšetkým poskytovať komplexnú ambulantnú a ústavnú zdravotnú starostlivosť pacientom s onkologickým ochorením – diagnostika, liečba a dispenzárna starostlivosť o onkologických pacientov. V ústavnej starostlivosti zabezpečuje onkologickú, onko-otorinolaryngologickú, onko-gynekologickú starostlivosť, komplexnú protinádorovú liečbu – radiačnú a chemoterapeutickú liečbu. Okrem iného zabezpečuje teoretickú i praktickú časť výučby žiakov stredných zdravotníckych škôl, teoretickú i praktickú časť vysokoškolského vzdelávania v zdravotníckych povolaniach."

During the past decade, Vychodoslovensky onkologicky ustav Oddelenie klinickej onkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vychodoslovensky onkologicky ustav Oddelenie klinickej onkologie" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Vychodoslovensky onkologicky ustav Oddelenie klinickej onkologie" are "Metastatic Colorectal Cancer" (2 trials). Many other conditions were trialed in "Vychodoslovensky onkologicky ustav Oddelenie klinickej onkologie" in a lesser frequency.

Most popular intervention types in "Vychodoslovensky onkologicky ustav Oddelenie klinickej onkologie" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab control" (1 trials), "Bevacizumab experimental" (1 trials), "Capecitabine" (1 trials), "Trifluridine/Tipiracil hydrochloride (S95005)" (1 trials) and "Trifluridine/tipiracil hydrochloride (S95005)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vychodoslovensky onkologicky ustav Oddelenie klinickej onkologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Vychodoslovensky onkologicky ustav Oddelenie klinickej onkologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Vychodoslovensky onkologicky ustav Oddelenie klinickej onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vychodoslovensky onkologicky ustav Oddelenie klinickej onkologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".